Here’s Why It’s Important to Call the Johnson & Johnson Vaccine Review Phase a ‘Pause’

“The stakes are high right now,” Professor Wendy Parmet tells Northeastern News. “We want a vaccine that is safe and we want to save lives, but we don’t want to give a vaccine to subpopulations that may be particularly vulnerable to it if we have other choices for them.”